| COVID-19 and Mental Health | Lifetime | 276 | QA 2 | 97.58 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 114 | QA 2 | 96.51 |
| COVID-19 and healthcare impacts | Lifetime | 687 | QA 2 | 93.42 |
| Healthcare professionals’ stress and burnout | Lifetime | 581 | QA 1 | 94.47 |
| Artificial Intelligence in Healthcare | Lifetime | 423 | QA 4 | 92.07 |
| COVID-19 Pandemic Impacts | Lifetime | 499 | QA 3 | 91.16 |
| Telemedicine and Telehealth Implementation | Lifetime | 644 | QA 2 | 89.78 |
| COVID-19 and Mental Health | 2021-2025 | 21 | QA 1 | 99.59 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 29 | QA 1 | 98.72 |
| Healthcare professionals’ stress and burnout | 2021-2025 | 31 | QA 1 | 98.31 |
| COVID-19 and healthcare impacts | 2021-2025 | 149 | QA 1 | 96.72 |
| Long-Term Effects of COVID-19 | 2021-2025 | 255 | QA 1 | 97.11 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 123 | QA 1 | 97.58 |
| Artificial Intelligence in Healthcare | 2021-2025 | 105 | QA 1 | 95.26 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 97 | QA 1 | 95.07 |
| Health and Well-being Studies | 2021-2025 | 68 | QA 1 | 92.84 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 181 | QA 1 | 95.35 |
| Iron Metabolism and Disorders | 2021-2025 | 158 | QA 1 | 94.00 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 436 | QA 1 | 94.45 |
| Family and Patient Care in Intensive Care Units | 2021-2025 | 170 | QA 1 | 93.44 |
| Acute Ischemic Stroke Management | 2021-2025 | 839 | QA 1 | 94.24 |
| COVID-19 Pandemic Impacts | 2021-2025 | 490 | QA 3 | 87.82 |
| Disaster Response and Management | 2021-2025 | 309 | QA 4 | 86.56 |
| COVID-19 diagnosis using AI | 2021-2025 | 656 | QA 6 | 88.53 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 119 | QA 1 | 88.22 |
| Emotional Intelligence and Performance | 2021-2025 | 84 | QA 1 | 88.74 |
| Mental Health Treatment and Access | 2021-2025 | 701 | QA 5 | 88.21 |
| Antibiotic Use and Resistance | 2021-2025 | 786 | QA 4 | 87.38 |
| COVID-19 Impact on Reproduction | 2021-2025 | 725 | QA 4 | 84.08 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 842 | QA 2 | 85.86 |
| Muscle and Compartmental Disorders | 2021-2025 | 141 | QA 1 | 80.04 |
| Pneumothorax, Barotrauma, Emphysema | 2021-2025 | 64 | QA 2 | 74.22 |
| Bacillus and Francisella bacterial research | 2021-2025 | 421 | QA 1 | 77.04 |
| Patient Satisfaction in Healthcare | 2021-2025 | 540 | QA 1 | 77.98 |
| Machine Learning in Healthcare | 2021-2025 | 693 | QA 2 | 79.08 |
| Simulation-Based Education in Healthcare | 2021-2025 | 503 | QA 3 | 78.88 |
| Pleural and Pulmonary Diseases | 2021-2025 | 730 | QA 2 | 75.43 |
| Ethics in Clinical Research | 2021-2025 | 784 | QA 4 | 75.25 |
| Workplace Violence and Bullying | 2021-2025 | 244 | QA 1 | 71.69 |
| Global Health Workforce Issues | 2021-2025 | 934 | QA 1 | 71.23 |
| Cardiac tumors and thrombi | 2021-2025 | 904 | QA 4 | 67.60 |
| Quality and Safety in Healthcare | 2021-2025 | 226 | QA 1 | 70.34 |
| Neurological and metabolic disorders | 2021-2025 | 298 | QA 4 | 65.41 |
| Organizational and Employee Performance | 2021-2025 | 967 | QA 10 | 62.27 |
| Biliary and Gastrointestinal Fistulas | 2021-2025 | 736 | QA 1 | 59.38 |
| Nursing Roles and Practices | 2021-2025 | 492 | QA 1 | 59.69 |
| Testicular diseases and treatments | 2021-2025 | 989 | QA 2 | 57.80 |
| Infection Control in Healthcare | 2021-2025 | 510 | QA 1 | 57.28 |
| Vascular anomalies and interventions | 2021-2025 | 743 | QA 1 | 55.24 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 641 | QA 3 | 52.02 |
| Health and Conflict Studies | 2021-2025 | 447 | QA 2 | 53.43 |
| Healthcare Education and Workforce Issues | 2021-2025 | 856 | QA 1 | 52.01 |
| Nursing education and management | 2021-2025 | 819 | QA 3 | 46.46 |
| Nursing Education, Practice, and Leadership | 2021-2025 | 112 | QA 1 | 43.09 |
| Otolaryngology and Infectious Diseases | 2021-2025 | 593 | QA 2 | 33.33 |
